Literature DB >> 9182950

Neurite outgrowth inhibitor of gliotic brain tissue. Mode of action and cellular localization, studied with specific monoclonal antibodies.

P Bovolenta1, I Fernaud-Espinosa, R Méndez-Otero, M Nieto-Sampedro.   

Abstract

Membranes from injured adult rat brain express a heparan/chondroitin sulphate proteoglycan that inhibits neurite outgrowth in vitro. We have developed monoclonal antibodies (Mabs) against this proteoglycan, two of which were characterized and used for the study of the inhibitor mode of action and localization in normal and injured adult brain. The antibodies recognized a molecule of apparent molecular weight 200 kDa in Western blots of injured brain membranes. One of the Mabs blocked both the inhibition of neurite outgrowth and the growth cone collapse activity, associated with the proteoglycan. In adult brain, inhibitor immunoreactivity was found predominantly in neurons but, after a lesion, it was associated mainly with reactive glial cells. The localization of neurite outgrowth inhibitors in reactive glia supports the idea that gliotic tissue is largely responsible for the failure of axonal regeneration in mammalian CNS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9182950     DOI: 10.1111/j.1460-9568.1997.tb01448.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  14 in total

1.  The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.

Authors:  R J McKeon; M J Jurynec; C R Buck
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 2.  The transitional zone and CNS regeneration.

Authors:  J P Fraher
Journal:  J Anat       Date:  1999-02       Impact factor: 2.610

3.  Increased adenine nucleotide translocator 1 in reactive astrocytes facilitates glutamate transport.

Authors:  Charles R Buck; Michael J Jurynec; Deepak K Gupta; Alick K T Law; Johannes Bilger; Douglas C Wallace; Robert J McKeon
Journal:  Exp Neurol       Date:  2003-06       Impact factor: 5.330

Review 4.  Central nervous system lesions that can and those that cannot be repaired with the help of olfactory bulb ensheathing cell transplants.

Authors:  Manuel Nieto-Sampedro
Journal:  Neurochem Res       Date:  2003-11       Impact factor: 3.996

Review 5.  Recent therapeutic strategies for spinal cord injury treatment: possible role of stem cells.

Authors:  D Garbossa; M Boido; M Fontanella; C Fronda; A Ducati; A Vercelli
Journal:  Neurosurg Rev       Date:  2012-04-27       Impact factor: 3.042

6.  Astroglial injury in an ex vivo model: contributions to its analysis in enriched cell cultures.

Authors:  Ximena A Lanosa; Jorge A Colombo
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-07-06       Impact factor: 2.416

7.  Cholesterol and matrisome pathways dysregulated in astrocytes and microglia.

Authors:  Julia Tcw; Lu Qian; Nina H Pipalia; Michael J Chao; Shuang A Liang; Yang Shi; Bharat R Jain; Sarah E Bertelsen; Manav Kapoor; Edoardo Marcora; Elizabeth Sikora; Elizabeth J Andrews; Alessandra C Martini; Celeste M Karch; Elizabeth Head; David M Holtzman; Bin Zhang; Minghui Wang; Frederick R Maxfield; Wayne W Poon; Alison M Goate
Journal:  Cell       Date:  2022-06-23       Impact factor: 66.850

Review 8.  CNS injury, glial scars, and inflammation: Inhibitory extracellular matrices and regeneration failure.

Authors:  Michael T Fitch; Jerry Silver
Journal:  Exp Neurol       Date:  2007-05-31       Impact factor: 5.330

9.  Clonal astrocytic response to cortical injury.

Authors:  Eduardo Martín-López; Jorge García-Marques; Raúl Núñez-Llaves; Laura López-Mascaraque
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

10.  Glial scar formation occurs in the human brain after ischemic stroke.

Authors:  Lijie Huang; Zhe-Bao Wu; Qichuan Zhuge; Weiming Zheng; Bei Shao; Brian Wang; Fen Sun; Kunlin Jin
Journal:  Int J Med Sci       Date:  2014-02-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.